Human brucellosis still presents scientists and clinicians with several challenges, such as
the understanding of pathogenic mechanisms of Brucella spp, the identification of markers …

Brucellosis exists worldwide. The disease mainly spreads by ingestion of unpasteurized
dairy products. It is a systemic disease, and many systems can be involved. The clinical …

Perspectives for the Treatment of Brucellosis in the 21st Century: The Ioannina
Recommendations | PLOS Medicine Skip to main content Advertisement PLOS Medicine …

Despite the introduction of newer, less toxic antimicrobial agents, the aminoglycosides
continue to serve a useful role in the treatment of serious enterococcal, mycobacterial, and …

Abstract Thirty-five patients aged 14–74 years (average, 54 years) who had brucellar
spondylitis were treated between January 1991 and December 1997. The time from onset of …

Background Brucellosis is the most common zoonotic infection in the world. Several
antibiotics, separately or in combination, have been tried for treatment of human brucellosis …

As more original molecular protocols and subsequent modifications are described in the
literature, it has become difficult for those not directly involved in the development of these …

Background: The treatment of human brucellosis is controversial. The purpose of this study
was to search published clinical trial papers to provide a simple and effective treatment in …

Epididymoorchitis is a focal form of human brucellosis described in 2%–20% of patients with
brucellosis. We assessed 59 cases of Brucella epididymoorchitis (BEO) between 1991 and …

Soon after antibiotics were introduced into medical practice, authors pointed out that
microorganisms capable of surviving within phagocytic cells may be protected from the …